Relapsed Mantle Cell Lymphoma Presenting as “Sister Mary Joseph Nodule”

por Vaughn, Jennifer E., Gopal, Ajay K.
Publicado 2010

Acute Appendicitis in a Man Undergoing Therapy for Mantle Cell Lymphoma

por Linden, Michael, Gopal, Ajay, Edlefsen, Kerstin
Publicado 2012

Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation

por Currin, Erin-Siobhain R., Gopal, Ajay K.
Publicado 2012

Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma

por Yan, Fengting, Gopal, Ajay K., Graf, Solomon A.
Publicado 2017

Controversies in the Treatment of Follicular Lymphoma

por Hübel, Kai, Ghielmini, Michele, Ladetto, Marco, Gopal, Ajay K.
Publicado 2020

Spontaneous Remission of an Untreated, MYC and BCL2 Coexpressing, High-Grade B-Cell Lymphoma: A Case Report and Literature Review

por Potts, D. Alan, Fromm, Jonathan R., Gopal, Ajay K., Cassaday, Ryan D.
Publicado 2017

Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient

por Hill, Joshua A., Ujjani, Chaitra S., Greninger, Alexander L., Shadman, Mazyar, Gopal, Ajay K.
Publicado 2021

Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8(+) T-cells despite immune checkpoint signaling

por Greenbaum, Adam M., Fromm, Jonathan R., Gopal, Ajay K., Houghton, A. McGarry
Publicado 2022

Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy

por Zimmerman, Zachary, Scott, Bart L., Gopal, Ajay K., Sandmaier, Brenda M., Maloney, David G., Deeg, H. Joachim
Publicado 2011

Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma

por Greenbaum, Adam M., Green, Damian J., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Rasmussen, Heather, Press, Oliver W., Gopal, Ajay K.
Publicado 2018

Assessment of Left Ventricular, Right Ventricular, and Left Atrial Strain in Light-Chain Amyloidosis

por Leedy, Douglas J., Vasbinder, Alexi, Huang, Hans D., Fernandes, Robin, Cowan, Andrew J., Gopal, Ajay K., Kirkpatrick, James N., Libby, Edward N., Cheng, Richard K.
Publicado 2020

A Phase I trial of talazoparib in patients with advanced hematologic malignancies

por Gopal, Ajay K, Popat, Rakesh, Mattison, Ryan J, Menne, Tobias, Bloor, Adrian, Gaymes, Terry, Khwaja, Asim, Juckett, Mark, Chen, Ying, Cotter, Matthew J, Mufti, Ghulam J
Publicado 2021

Brentuximab vedotin, an antibody–drug conjugate, in patients with CD30‐positive haematologic malignancies and hepatic or renal impairment

por Zhao, Baiteng, Chen, Robert, O'Connor, Owen A., Gopal, Ajay K., Ramchandren, Radhakrishnan, Goy, Andre, Matous, Jeffrey V., Fasanmade, Adedigbo A., Manley, Thomas J., Han, Tae H.
Publicado 2016

Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic

por Richter, Maximilian, Yumul, Roma, Saydaminova, Kamola, Wang, Hongjie, Gough, Michael, Baldessari, Audrey, Cattaneo, Roberto, Lee, Frank, Wang, Chung-Huei Katherine, Jang, Haishan, Astier, Anne, Gopal, Ajay, Carter, Darrick, Lieber, André
Publicado 2016

Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial

por Balasubramanian, Sriram, Hodkinson, Brendan, Schuster, Stephen J., Fowler, Nathan H., Trotman, Judith, Hess, Georg, Cheson, Bruce D., Schaffer, Michael, Sun, Steven, Deshpande, Sanjay, Vermeulen, Jessica, Salles, Gilles, Gopal, Ajay K.
Publicado 2021

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

por Bartlett, Nancy L, Chen, Robert, Fanale, Michelle A, Brice, Pauline, Gopal, Ajay, Smith, Scott E, Advani, Ranjana, Matous, Jeffrey V, Ramchandren, Radhakrishnan, Rosenblatt, Joseph D, Huebner, Dirk, Levine, Pamela, Grove, Laurie, Forero-Torres, Andres
Publicado 2014

Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma

por Green, Damian J., Bensinger, William I., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Pagel, John M., Frayo, Shani L., Roden, Jennifer E., Hedin, Lacey, Press, Oliver W., Gopal, Ajay K.
Publicado 2016

Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer

por Hong, David S., Gopal, Ajay K., Shoushtari, Alexander N., Patel, Sandip P., He, Aiwu R., Doi, Toshihiko, Ramalingam, Suresh S., Patnaik, Amita, Sandhu, Shahneen, Chen, Ying, Davis, Craig B., Fisher, Timothy S., Huang, Bo, Fly, Kolette D., Ribas, Antoni
Publicado 2022

Anti-CD45 Radioimmunotherapy with (90)Y but Not (177)Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model

por Orozco, Johnnie J., Balkin, Ethan R., Gooley, Ted A., Kenoyer, Aimee, Hamlin, Donald K., Wilbur, D. Scott, Fisher, Darrell R., Hylarides, Mark D., Shadman, Mazyar, Green, Damian J., Gopal, Ajay K., Press, Oliver W., Pagel, John M.
Publicado 2014

Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia

por Vo, Phuong, Gooley, Ted A., Rajendran, Joseph G., Fisher, Darrell R., Orozco, Johnnie J., Green, Damian J., Gopal, Ajay K., Haaf, Robyn, Nartea, Margaret, Storb, Rainer, Appelbaum, Frederick R., Press, Oliver W., Pagel, John M., Sandmaier, Brenda M.
Publicado 2020